An Adeno-Associated Viral Vector Capable of Penetrating the Mucus Barrier to Inhaled Gene Therapy
Tóm tắt
Từ khóa
Tài liệu tham khảo
Griesenbach, 2009, Gene transfer to the lung: Lessons learned from more than 2 decades of CF gene therapy, Adv. Drug Deliv. Rev., 61, 128, 10.1016/j.addr.2008.09.010
Limberis, 2009, Transduction efficiencies of novel AAV vectors in mouse airway epithelium in vivo and human ciliated airway epithelium in vitro, Mol. Ther., 17, 294, 10.1038/mt.2008.261
Yan, 2013, A novel chimeric adenoassociated virus 2/human bocavirus 1 parvovirus vector efficiently transduces human airway epithelia, Mol. Ther, 21, 2181, 10.1038/mt.2013.92
Cooney, 2016, Lentiviral-mediated phenotypic correction of cystic fibrosis pigs, JCI Insight, 1, e88730, 10.1172/jci.insight.88730
Steines, 2016, CFTR gene transfer with AAV improves early cystic fibrosis pig phenotypes, JCI Insight, 1, e88728, 10.1172/jci.insight.88728
Flotte, 2010, Dual reporter comparative indexing of rAAV pseudotyped vectors in chimpanzee airway, Mol. Ther, 18, 594, 10.1038/mt.2009.230
Yan, 2017, Human bocavirus type-1 capsid facilitates the transduction of ferret airways by adeno-associated virus genomes, Hum. Gene Ther., 28, 612, 10.1089/hum.2017.060
Griesenbach, 2012, Assessment of F/HN-pseudotyped lentivirus as a clinically relevant vector for lung gene therapy, Am. J. Respir. Crit. Care Med., 186, 846, 10.1164/rccm.201206-1056OC
Alton, 2017, Preparation for a first-in-man lentivirus trial in patients with cystic fibrosis, Thorax, 72, 137, 10.1136/thoraxjnl-2016-208406
Excoffon, 2009, Directed evolution of adeno-associated virus to an infectious respiratory virus, Proc. Natl. Acad. Sci. USA, 106, 3865, 10.1073/pnas.0813365106
Gernoux, 2017, Regulatory and exhausted T cell responses to AAV capsid, Hum. Gene Ther., 28, 338, 10.1089/hum.2017.022
Tse, 2017, Structure-guided evolution of antigenically distinct adeno-associated virus variants for immune evasion, Proc. Natl. Acad. Sci. USA, 114, E4812, 10.1073/pnas.1704766114
Ferrari, 2002, Barriers to and new approaches for gene therapy and gene delivery in cystic fibrosis, Adv. Drug Deliv. Rev., 54, 1373, 10.1016/S0169-409X(02)00145-X
Kim, 2016, Barriers to inhaled gene therapy of obstructive lung diseases: A review, J. Control. Release, 240, 465, 10.1016/j.jconrel.2016.05.031
Mastorakos, 2015, Highly compacted biodegradable DNA nanoparticles capable of overcoming the mucus barrier for inhaled lung gene therapy, Proc. Natl. Acad. Sci. USA, 112, 8720, 10.1073/pnas.1502281112
Schneider, 2017, Nanoparticles that do not adhere to mucus provide uniform and long-lasting drug delivery to airways following inhalation, Sci. Adv., 3, e1601556, 10.1126/sciadv.1601556
Suk, 2014, Lung gene therapy with highly compacted DNA nanoparticles that overcome the mucus barrier, J. Control. Release, 178, 8, 10.1016/j.jconrel.2014.01.007
Suk, 2016, Could recent advances in DNA-loaded nanoparticles lead to effective inhaled gene therapies?, Nanomedicine (Lond.), 11, 193, 10.2217/nnm.15.194
Forier, 2013, Transport of nanoparticles in cystic fibrosis sputum and bacterial biofilms by single-particle tracking microscopy, Nanomedicine (Lond.), 8, 935, 10.2217/nnm.12.129
Fahy, 2010, Airway mucus function and dysfunction, N. Engl. J. Med., 363, 2233, 10.1056/NEJMra0910061
Knowles, 2002, Mucus clearance as a primary innate defense mechanism for mammalian airways, J. Clin. Invest., 109, 571, 10.1172/JCI0215217
Hida, 2011, Common gene therapy viral vectors do not efficiently penetrate sputum from cystic fibrosis patients, PLoS ONE, 6, e19919, 10.1371/journal.pone.0019919
Schuster, 2014, Overcoming the cystic fibrosis sputum barrier to leading adeno-associated virus gene therapy vectors, Mol. Ther., 22, 1484, 10.1038/mt.2014.89
Li, 2011, AAV-6 mediated efficient transduction of mouse lower airways, Virology, 417, 327, 10.1016/j.virol.2011.06.009
Kurosaki, 2017, Optimization of adeno-associated virus vector-mediated gene transfer to the respiratory tract, Gene Ther., 24, 290, 10.1038/gt.2017.19
McClain, 2016, Vector serotype screening for use in ovine perinatal lung gene therapy, J. Pediatr. Surg., 51, 879, 10.1016/j.jpedsurg.2016.02.048
Liu, 2007, Biological differences in rAAV transduction of airway epithelia in humans and in old world non-human primates, Mol. Ther., 15, 2114, 10.1038/sj.mt.6300277
Liu, 2007, Comparative biology of rAAV transduction in ferret, pig and human airway epithelia, Gene Ther., 14, 1543, 10.1038/sj.gt.3303014
Duncan, 2016, Microstructural alterations of sputum in cystic fibrosis lung disease, JCI Insight, 1, e88198, 10.1172/jci.insight.88198
Henderson, 2014, Cystic fibrosis airway secretions exhibit mucin hyperconcentration and increased osmotic pressure, J. Clin. Invest., 124, 3047, 10.1172/JCI73469
Schuster, 2015, Particle tracking in drug and gene delivery research: state-of-the-art applications and methods, Adv. Drug Deliv. Rev., 91, 70, 10.1016/j.addr.2015.03.017
Wu, 2006, Single amino acid changes can influence titer, heparin binding, and tissue tropism in different adeno-associated virus serotypes, J. Virol., 80, 11393, 10.1128/JVI.01288-06
Sagel, 2007, Sputum biomarkers of inflammation in cystic fibrosis lung disease, Proc. Am. Thorac. Soc., 4, 406, 10.1513/pats.200703-044BR
Ribeiro, 2009, Azithromycin treatment alters gene expression in inflammatory, lipid metabolism, and cell cycle pathways in well-differentiated human airway epithelia, PLoS ONE, 4, e5806, 10.1371/journal.pone.0005806
Mall, 2004, Increased airway epithelial Na+ absorption produces cystic fibrosis-like lung disease in mice, Nat. Med., 10, 487, 10.1038/nm1028
Mall, 2008, Development of chronic bronchitis and emphysema in beta-epithelial Na+ channel-overexpressing mice, Am. J. Respir. Crit. Care Med., 177, 730, 10.1164/rccm.200708-1233OC
Huang, 2017, Protein nanocages that penetrate airway mucus and tumor tissue, Proc. Natl. Acad. Sci. USA, 114, E6595, 10.1073/pnas.1705407114
Zhang, 2009, CFTR delivery to 25% of surface epithelial cells restores normal rates of mucus transport to human cystic fibrosis airway epithelium, PLoS Biol., 7, e1000155, 10.1371/journal.pbio.1000155
Wu, 2006, α2,3 and α2,6 N-linked sialic acids facilitate efficient binding and transduction by adeno-associated virus types 1 and 6, J. Virol., 80, 9093, 10.1128/JVI.00895-06
Sanders, 2000, Cystic fibrosis sputum: a barrier to the transport of nanospheres, Am. J. Respir. Crit. Care Med., 162, 1905, 10.1164/ajrccm.162.5.9909009
Suk, 2011, N-acetylcysteine enhances cystic fibrosis sputum penetration and airway gene transfer by highly compacted DNA nanoparticles, Mol. Ther., 19, 1981, 10.1038/mt.2011.160
Schuster, 2013, Nanoparticle diffusion in respiratory mucus from humans without lung disease, Biomaterials, 34, 3439, 10.1016/j.biomaterials.2013.01.064
Kesimer, 2017, Airway mucin concentration as a marker of chronic bronchitis, N. Engl. J. Med., 377, 911, 10.1056/NEJMoa1701632
Xie, 2011, Structure-function analysis of receptor-binding in adeno-associated virus serotype 6 (AAV-6), Virology, 420, 10, 10.1016/j.virol.2011.08.011
Bals, 1999, Transduction of well-differentiated airway epithelium by recombinant adeno-associated virus is limited by vector entry, J. Virol., 73, 6085, 10.1128/JVI.73.7.6085-6088.1999
Yan, 2004, Distinct classes of proteasome-modulating agents cooperatively augment recombinant adeno-associated virus type 2 and type 5-mediated transduction from the apical surfaces of human airway epithelia, J. Virol., 78, 2863, 10.1128/JVI.78.6.2863-2874.2004
Mitomo, 2010, Toward gene therapy for cystic fibrosis using a lentivirus pseudotyped with Sendai virus envelopes, Mol. Ther., 18, 1173, 10.1038/mt.2010.13
Aslanidi, 2013, Optimization of the capsid of recombinant adeno-associated virus 2 (AAV2) vectors: the final threshold?, PLoS ONE, 8, e59142, 10.1371/journal.pone.0059142
Pandya, 2014, Rationally designed capsid and transgene cassette of AAV6 vectors for dendritic cell-based cancer immunotherapy, Immunol. Cell Biol., 92, 116, 10.1038/icb.2013.74
Sayroo, 2016, Development of novel AAV serotype 6 based vectors with selective tropism for human cancer cells, Gene Ther., 23, 18, 10.1038/gt.2015.89
Cozens, 1992, Characterization of immortal cystic fibrosis tracheobronchial gland epithelial cells, Proc. Natl. Acad. Sci. USA, 89, 5171, 10.1073/pnas.89.11.5171
Horani, 2013, Rho-associated protein kinase inhibition enhances airway epithelial Basal-cell proliferation and lentivirus transduction, Am. J. Respir. Cell Mol. Biol., 49, 341, 10.1165/rcmb.2013-0046TE